During the six months ended March 31, 2011, Accentia
Biopharmaceuticals Inc. had a net loss of US$8.5 million. On
March 31, 2011, the Company had an accumulated deficit of
approximately…
GTC Biotherapeutics, Inc. has negative working capital of US$13.1 million as of April 4, 2010. The Company had negative working capital of US$16.1 million as of January 3, 2010.
The Company…
AE Biofuels, Inc. has negative working capital of US$19.1 million at March 31, 2010, as compared to negative working capital of US$17.9 million at December 31, 2009. The Company’s current…
AE Biofuels, Inc.’s working capital deficit increased by 3%, or US$375,000, from US$11.34 million at Dec. 31, 2008 to US$11.72 million at March 31, 2009.
The Company reported US$833,000 in current…
Human Genome Sciences, Inc. reported a working capital deficit of US$52.54 million at Dec. 31, 2008, compared to a positive working capital of US$46.95 million at Dec. 31, 2007.
The Company…
Oscient Pharmaceuticals Corporation reported a working capital deficit of US$11.37 million at Sept. 30, 2008, according to its Registration Statement filed on Form S-1 with the U.S. Securities and Exchange…
Genta Incorporated reported a working capital deficit of US$5.22 million at Dec. 31, 2008, compared to a positive working capital of US$877,000 at Dec. 31, 2007.
The Company had US$6.00 million…